The Australian National Audit Office has extended the deadline for stakeholders to contribute to its performance audit of the administration of the PBS.
-
Latest News
Groups call for a new approach to reviewing and funding cancer medicines
Several advocacy groups, including Rare Cancers Australia, have called for a change in how precision cancer medicines are evaluated and recommended.
-
Latest News Auditor General extends time to contribute to PBS performance audit March 28, 2024
-
Latest News Gilead announces eight recipients of inaugural Community Grants Program March 28, 2024Gilead has awarded $260,000 to support various Australian patient and community organisations in their ongoing work to improve the health and wellness of people living with bloodborne viruses and cancers.
-
Latest News Reform bill redefines political donation and could exclude the industry from participating March 27, 2024Independent Senator David Pocock is leading a push by federal crossbenchers to reform electoral donation laws. This would redefine what constitutes a donation, capturing payments that currently fall outside the disclosure obligation and potentially ban donations from organisations that supply the Commonwealth.
-
Podcast The 'Week in Review' Podcast - 22 March March 21, 2024Where do we start? Last year, the minister described Australia's HTA decision-making as clunky and agreed that it led to unnecessary deaths. How does that admission sit with his latest appointments? We start putting together the pieces of a worrying puzzle and constructing a timeline.
-
Latest News NZ Government delivers funding boost for patients travelling to health treatment March 27, 2024“The coalition Government has already committed to delivering better health outcomes for New Zealanders by improving access to medicines and other treatments," said Health Minister Dr Shane Reti.
-
Australian Biotech Clarity Pharmaceuticals launches $121 million fully underwritten equity raising March 26, 2024Australian clinical-stage radiopharmaceutical company Clarity Pharmaceuticals (ASX:CU6) has announced a fully underwritten $121 million equity raising comprising a pro-rata accelerated non-renounceable entitlement offer and placement to institutional investors.
-
Latest News More states announce RSV programs as families call for national action March 26, 2024“We believe a national RSV program is needed so all infants born in Australia have access to Beyfortus. A national program for next year’s RSV season will make it easier for parents and healthcare professionals to discuss infant eligibility, no matter where the child is born," said Regis Launay, the general manager of vaccines for Sanofi Australia and New Zealand.
-
Latest News New study reveals impact of restrictions imposed on PBS-listed opioids March 26, 2024A newly published study has found that the use of PBS-listed opioids declined following restrictions on the number of repeat prescriptions, smaller pack sizes and tighter authority.
-
Latest News Pfizer releases 2023 Impact Report revealing progress on environment and pipeline March 26, 2024“I am proud of Pfizer’s commitment to tackling the challenges that face our society through initiatives that support a number of underserved and vulnerable communities around the world," said Anne Harris, the managing director of Pfizer Australia and New Zealand.
-
Latest News Painaustralia CEO goes red for the 1.9 million women living with invisible chronic pain March 26, 2024Painaustralia CEO Giulia Jones has dyed her hair red as part of her campaign to raise awareness and funding for the 1.9 million women living with chronic pain.
-
Latest News Once again, history is the guide in that these appointments are a response March 25, 2024Committee appointments have always been a response. What do these appointments indicate about the Government's policy decisions, priorities and plans for health technologies?
-
Latest News If the Government expands their power, they need to be made more accountable March 25, 2024The exclusion of the PBS and other funding processes and decisions from administrative review is confounded by proposals to significantly expand the remit and power of health technology assessment advisory committees.
-
Latest News New Zealand moves closer to funding CGM as Australia waits for tender outcome March 25, 2024New Zealand's Pharmac has announced it has concluded its evaluation of continuous glucose monitors, insulin pumps and insulin pump consumables and is now negotiating contracts with preferred suppliers.
-
Latest News 'Focus on making high-quality intellectual cases in support of spending and new ideas' March 22, 2024The comments of Australia's former most senior bureaucrat at a previous BioPharmaDispatch conference are informative for the industry as it navigates significant uncertainty.
-
Latest News Chemist Warehouse reveals rapid growth in Sigma full-year results March 21, 2024Sigma announced a revenue reduction but higher earnings for the 12 months to the end of January 2024, during which it divested its hospital distribution business and announced a merger with the fast-growing Chemist Warehouse Group.
-
Latest News New 'Mind the Treatment Gap' campaign to focus attention on drug-resistant epilepsy March 22, 2024A new campaign has been launched focused on helping Australians living with drug-resistant epilepsy to understand available treatment options better and access them sooner.
-
Latest News Look at these appointments and ideas like the pieces of a puzzle coming together March 21, 2024Set these and other cent appointments against the backdrop of the proposals in the recently released and controversial Health Technology Assessment Review options paper.
-
Latest News Australian patients now one step closer to accessing CSL's one-time gene therapy March 21, 2024"The approval of HEMGENIX reflects groundbreaking science in delivering a medicine that we believe can transform the treatment options for both the people living with haemophilia B and the healthcare professionals who treat them,” said Dr Andrew Nash, senior vice president, head of research and chief scientific officer at CSL.
-
Latest News GBMA announces board changes at a 'pivotal time' in Australia’s medicines policy March 21, 2024“The GBMA board will continue to prioritise the needs of Australia’s most vulnerable patients, in particular those struggling with the financial and health burden of chronic disease,” said GBMA chair Professor Jane Halton AO PSM.
Australian Biotech
-
Clarity Pharmaceuticals launches $121 million fully underwritten equity raising
March 26, 2024 -
Cochlear announces the resignation of non-executive director Yasmin Allen AM
March 25, 2024 -
Orthocell completes all nerve repair surgeries in Remplir US market authorisation study
March 25, 2024 -
LTR Pharma says first patient, first dose in the SPONTAN pivotal clinical study
March 20, 2024 -
Rhythm Biosciences establishes internationally renowned clinical advisory board
March 20, 2024
Other Health
-
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024 -
Medibank offering members $50 to put towards dental out-of-pocket costs
February 7, 2024 -
US FDA approves Edwards' Evoque system for major heart valve disease
February 7, 2024 -
Private health insurers say price gouging doctors should be named and shamed
February 7, 2024 -
Medibank releases its top private health insurance claims for 2023
December 13, 2023
Latest Video
New Stories
-
Gilead announces eight recipients of inaugural Community Grants Program
March 28, 2024 - - Latest News -
Groups call for a new approach to reviewing and funding cancer medicines
March 28, 2024 - - Latest News -
Auditor General extends time to contribute to PBS performance audit
March 28, 2024 - - Latest News -
Reform bill redefines political donation and could exclude the industry from participating
March 27, 2024 - - Latest News -
NZ Government delivers funding boost for patients travelling to health treatment
March 27, 2024 - - Latest News -
Clarity Pharmaceuticals launches $121 million fully underwritten equity raising
March 26, 2024 - - Australian Biotech -
More states announce RSV programs as families call for national action
March 26, 2024 - - Latest News